ISSN: 1750-6123
Journal Home
Journal Guideline
International Journal of Pharmaceutical and Healthcare Marketing Q3 Unclaimed
International Journal of Pharmaceutical and Healthcare Marketing is a journal indexed in SJR in Marketing and Health Policy with an H index of 30. It has an SJR impact factor of 0,337 and it has a best quartile of Q3. It has an SJR impact factor of 0,337.
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -




- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,337
SJR Impact factor30
H Index42
Total Docs (Last Year)97
Total Docs (3 years)3141
Total Refs217
Total Cites (3 years)96
Citable Docs (3 years)1.65
Cites/Doc (2 years)74.79
Ref/DocOther journals with similar parameters
Qualitative Market Research Q3
Sport, Business and Management: An International Journal Q3
Sports, Business and Management Q3
Place Branding and Public Diplomacy Q3
International Journal of Applied Ceramic Technology Q3
Compare this journals
Aims and Scope
Best articles by citations
Public health, healthcare innovations and marketing
View moreVault Career Guide to Pharmaceutical Sales and Marketing: Get the Inside Scoop on Pharma Sales and Marketing Careers20111Carole S. Moussalli. Vault Career Guide to Pharmaceutical Sales and Marketing: Get the Inside Scoop on Pharma Sales and Marketing
View moreA consumer adoption model for personalized medicine: an exploratory study
View moreThe Strategic Pricing of Pharmaceuticals20121E.M. (Mick) Kolassa. The Strategic Pricing of Pharmaceuticals. Gilsum, New Hampshire: The PondHouse Press 2009. 292 pp., ISBN: 978-0982371503
View moreThe link between hospital quality and services profitability
View moreThe impact of mobile health monitoring on the evolution of patient-pharmacist relationships
View moreDrugs and Money -Prices, Affordability and Cost Containment20111M.N.G. Dukes, F.M. Haaijer-Ruskamp, C.P. de Joncheere and A.H. Rietveld. Drugs and Money -Prices, Affordability and Cost Containment. Amsterdam: IOS Press 2003. 158 pp., ISBN: 1 58603 33
View moreA new company descriptor takes us into a new era
View moreSelling stem cell based biologics and salesforce alignment for the biomedical device industry
View moreConsumer responses to direct to consumer prescription drug advertising
View moreAdvances in pharmaceutical marketing: theoretical and empirical foundations
View moreNew year, new opportunities, new agendas
View moreIsrael Cancer Association: promoting the fight against breast cancer with IMC strategy
View moreEditorial
View moreRelating patient satisfaction to nurses' job satisfaction, job security, and obedience OCBs
View moreWeb-enabled product ID system as a tool in pharmaceutical marketing
View moreA review of the second year of IJPHM
View moreAn exciting new year for IJPHM
View moreSenior services: exploring nursing home services for community-based seniors
View moreThree years of IJPHM: review and reflection
View moreThe uses and potential of biometrics in health care
View moreThe Politics of Heath Legislation: An Economic Perspective (3rd ed.)20091Paul J. Feldstein. The Politics of Heath Legislation: An Economic Perspective (3rd ed.). Chicago, IL: Health Administration Press 2008. 404 pp., ISBN: 978-1-56793-253-9
View moreWealth effects of the pharmaceutical industry-physician interaction compliance guidelines on large pharmaceutical companies
View moreGlobal Pharmaceutical Marketing: A Practical Guide to Codes and Compliance20091Judith Grice. Global Pharmaceutical Marketing: A Practical Guide to Codes and Compliance. London: Pharmaceutical Press 2008. 218 pp., ISBN: 9780853697176
View more
Comments